TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, 2025, stating them as inaccurate and misleading.
TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, 2025, stating them as inaccurate and misleading.
Scorpion Capital alleges that the NOP operates as an “unsustainable, anti-competitive scheme” involving coercive tying, price extortion, and retaliation. The report further claims the NOP ...
If you purchased TransMedics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a ...
The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT IS THIS ABOUT: On January 10, 2025, Scorpion Capital issued a report about TransMedics. In this report, ...